Sign inJoin waitlistJoin the waitlist

Stephanie Goff

Head, Clinical Operations for Surgery Branch cGMP Facilities · Clinical Center at the National Institutes of Health

Credentials: · · · ·

History

Clinical Operations for Surgery Branch cGMP Facilities Division · Clinical Center at the National Institutes of Health
Present
Clinical Center at the National Institutes of Health
Present

Complex General Surgical Oncology
Brigham and Women's Hospital
2012–2014
Surgery
New York Presbyterian Hospital
2007–2012
Doctor of Medicine
2003–2007
Institute

Research

Adoptive cell therapy for patients with metastatic melanoma: evaluation of intensive myeloablative chemoradiation preparative regimens
Journal of Clinical Oncology · 2008 · 1,104 citations
Immune recognition of somatic mutations leading to complete durable regression in metastatic breast cancer
Nature Medicine · 2018 · 636 citations
Prognostic factors related to clinical response in patients with metastatic melanoma treated by CTL-associated antigen-4 blockade
Clinical Cancer Research · 2007 · First of 15 authors · 542 citations

Steven Rosenberg
56 papers · 12 as a fellow
James Yang
36 papers
Nicholas Klemen
12 papers · 2 as a resident
Udai Kammula
12 papers
Billel Gasmi
11 papers · 5 as a resident
Aaron Dinerman
10 papers · 10 as a fellow
Alexandra Gustafson
8 papers · 8 as a fellow
Amy Copeland
7 papers · 5 as a fellow
James Kochenderfer
7 papers
Jonathan Hernandez
7 papers
Kyle Hitscherich
7 papers · 7 as a fellow
Shoshana Levi
7 papers

Clinical trials

Phase II Trial of Combination Anti-PD-1 and Aldesleukin for Metastatic Melanoma and Renal Cell Carcinoma
Principal investigator · Recruiting · Phase 2
National Cancer Institute (NCI)
2022–2031
A Phase 2 Trial for Metastatic Melanoma Using Adoptive Cell Therapy With Tumor Infiltrating Lymphocytes Plus IL-2 Either Alone or Following the Administration of Pembrolizumab
Principal investigator · Recruiting · Phase 2
National Cancer Institute (NCI)
2015–2029
Immunotherapy Using Tumor Infiltrating Lymphocytes for Patients With Metastatic Melanoma
Principal investigator · Completed · Phase 2
National Cancer Institute (NCI)
2013–2022